nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—brainstem—narcolepsy	0.0267	0.0666	CbGeAlD
Acetylsalicylic acid—NFKBIA—brainstem—narcolepsy	0.0263	0.0656	CbGeAlD
Acetylsalicylic acid—TP53—forebrain—narcolepsy	0.0258	0.0643	CbGeAlD
Acetylsalicylic acid—HSPA5—brainstem—narcolepsy	0.0257	0.0642	CbGeAlD
Acetylsalicylic acid—NFKBIA—forebrain—narcolepsy	0.0253	0.0633	CbGeAlD
Acetylsalicylic acid—HSPA5—forebrain—narcolepsy	0.0248	0.062	CbGeAlD
Acetylsalicylic acid—RPS6KA3—forebrain—narcolepsy	0.0211	0.0528	CbGeAlD
Acetylsalicylic acid—NFKBIA—medulla oblongata—narcolepsy	0.0183	0.0457	CbGeAlD
Acetylsalicylic acid—HSPA5—medulla oblongata—narcolepsy	0.0179	0.0448	CbGeAlD
Acetylsalicylic acid—NFKBIA—midbrain—narcolepsy	0.0167	0.0418	CbGeAlD
Acetylsalicylic acid—HSPA5—midbrain—narcolepsy	0.0164	0.0409	CbGeAlD
Acetylsalicylic acid—RPS6KA3—medulla oblongata—narcolepsy	0.0153	0.0381	CbGeAlD
Acetylsalicylic acid—RPS6KA3—midbrain—narcolepsy	0.014	0.0349	CbGeAlD
Acetylsalicylic acid—EDNRA—medulla oblongata—narcolepsy	0.0124	0.031	CbGeAlD
Acetylsalicylic acid—EDNRA—midbrain—narcolepsy	0.0113	0.0283	CbGeAlD
Acetylsalicylic acid—TP53—brain—narcolepsy	0.0107	0.0267	CbGeAlD
Acetylsalicylic acid—NFKBIA—brain—narcolepsy	0.0105	0.0263	CbGeAlD
Acetylsalicylic acid—HSPA5—brain—narcolepsy	0.0103	0.0257	CbGeAlD
Acetylsalicylic acid—RPS6KA3—brain—narcolepsy	0.00877	0.0219	CbGeAlD
Acetylsalicylic acid—EDNRA—brain—narcolepsy	0.00713	0.0178	CbGeAlD
Acetylsalicylic acid—IKBKB—brain—narcolepsy	0.00647	0.0162	CbGeAlD
Acetylsalicylic acid—SLC22A7—brain—narcolepsy	0.00628	0.0157	CbGeAlD
Acetylsalicylic acid—SLC22A6—brain—narcolepsy	0.00606	0.0151	CbGeAlD
Acetylsalicylic acid—PTGS1—forebrain—narcolepsy	0.00519	0.013	CbGeAlD
Acetylsalicylic acid—PTGS2—forebrain—narcolepsy	0.00496	0.0124	CbGeAlD
Acetylsalicylic acid—NFKBIA—TCR signaling—HLA-DRB1—narcolepsy	0.00467	0.00779	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00444	0.00741	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00444	0.00741	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00437	0.00729	CbGpPWpGaD
Acetylsalicylic acid—ALB—FOXA2 and FOXA3 transcription factor networks—CPT1B—narcolepsy	0.00433	0.00722	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00429	0.00716	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—narcolepsy	0.00419	0.00699	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—G alpha (q) signalling events—TRH—narcolepsy	0.00417	0.00696	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Peptide ligand-binding receptors—TRH—narcolepsy	0.00412	0.00687	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—SOCS2—narcolepsy	0.00394	0.00657	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream TCR signaling—HLA-DQA1—narcolepsy	0.00391	0.00652	CbGpPWpGaD
Acetylsalicylic acid—ALB—brain—narcolepsy	0.00378	0.00944	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00373	0.00623	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00373	0.00623	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream TCR signaling—HLA-DQB1—narcolepsy	0.00366	0.0061	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00365	0.00608	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—medulla oblongata—narcolepsy	0.00358	0.00895	CbGeAlD
Acetylsalicylic acid—NFKBIA—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—narcolepsy	0.00352	0.00586	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—HCRTR1—narcolepsy	0.00338	0.00564	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—HCRTR2—narcolepsy	0.00338	0.00564	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—midbrain—narcolepsy	0.00328	0.00818	CbGeAlD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—P2RY11—narcolepsy	0.00327	0.00545	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00325	0.00542	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCRs, Other—HTR2A—narcolepsy	0.00325	0.00541	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TNFRSF1B—narcolepsy	0.00321	0.00535	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—IL23-mediated signaling events—TNF—narcolepsy	0.00321	0.00535	CbGpPWpGaD
Acetylsalicylic acid—TP53—Circadian rythm related genes—NPS—narcolepsy	0.00317	0.00528	CbGpPWpGaD
Acetylsalicylic acid—TP53—Amyotrophic lateral sclerosis (ALS)—TNF—narcolepsy	0.0031	0.00518	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—SOCS2—narcolepsy	0.00308	0.00513	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—forebrain—narcolepsy	0.00307	0.00766	CbGeAlD
Acetylsalicylic acid—EDNRA—G alpha (q) signalling events—NPS—narcolepsy	0.00303	0.00506	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—G alpha (q) signalling events—TAC1—narcolepsy	0.00303	0.00506	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis Modulation and Signaling—TNFRSF1B—narcolepsy	0.00301	0.00502	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Peptide ligand-binding receptors—TAC1—narcolepsy	0.00299	0.00499	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Peptide ligand-binding receptors—NPS—narcolepsy	0.00299	0.00499	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—TNFRSF1B—narcolepsy	0.00298	0.00498	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00297	0.00495	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR signaling—HLA-DQA1—narcolepsy	0.00292	0.00487	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TWEAK Signaling Pathway—TNF—narcolepsy	0.0029	0.00483	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00283	0.00472	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream TCR signaling—HLA-DRB1—narcolepsy	0.00278	0.00464	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—HCRT—narcolepsy	0.00278	0.00463	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00276	0.00461	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR signaling—HLA-DQB1—narcolepsy	0.00273	0.00456	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00271	0.00452	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00271	0.00452	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00271	0.00452	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00271	0.00452	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—brain—narcolepsy	0.00266	0.00663	CbGeAlD
Acetylsalicylic acid—NFKBIA—Ceramide signaling pathway—TNF—narcolepsy	0.00261	0.00435	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—PENK—narcolepsy	0.00248	0.00413	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00242	0.00404	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—SOCS2—narcolepsy	0.00226	0.00377	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—medulla oblongata—narcolepsy	0.00222	0.00554	CbGeAlD
Acetylsalicylic acid—IKBKB—Type II diabetes mellitus—TNF—narcolepsy	0.00216	0.00361	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—brain—narcolepsy	0.00215	0.00538	CbGeAlD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—TRH—narcolepsy	0.00211	0.00351	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Canonical NF-kappaB pathway—TNF—narcolepsy	0.00209	0.00348	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—EBV LMP1 signaling—TNF—narcolepsy	0.00209	0.00348	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR signaling—HLA-DRB1—narcolepsy	0.00208	0.00346	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—brain—narcolepsy	0.00206	0.00514	CbGeAlD
Acetylsalicylic acid—ABCB1—midbrain—narcolepsy	0.00203	0.00506	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Immune System—SOCS2—narcolepsy	0.00202	0.00337	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00201	0.00335	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00201	0.00335	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Overview of nanoparticle effects—TNF—narcolepsy	0.002	0.00334	CbGpPWpGaD
Acetylsalicylic acid—TP53—Folate Metabolism—TNF—narcolepsy	0.002	0.00333	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—CHKB—narcolepsy	0.00195	0.00325	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling events mediated by HDAC Class I—TNF—narcolepsy	0.00193	0.00321	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—HCRTR2—narcolepsy	0.00191	0.00319	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—HCRTR1—narcolepsy	0.00191	0.00319	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—narcolepsy	0.0019	0.00317	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—P2RY11—narcolepsy	0.00185	0.00308	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—HRH3—narcolepsy	0.00185	0.00308	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—G alpha (q) signalling events—HTR2A—narcolepsy	0.00182	0.00304	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00177	0.00296	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HCRTR1—narcolepsy	0.00174	0.0029	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HCRTR2—narcolepsy	0.00174	0.0029	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HCRTR1—narcolepsy	0.00174	0.0029	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HCRTR2—narcolepsy	0.00174	0.0029	CbGpPWpGaD
Acetylsalicylic acid—TP53—Alzheimers Disease—TNF—narcolepsy	0.00173	0.00288	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—P2RY11—narcolepsy	0.00168	0.0028	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—P2RY11—narcolepsy	0.00168	0.0028	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—MAPK Signaling Pathway—TNF—narcolepsy	0.00166	0.00278	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Apoptosis—TNF—narcolepsy	0.00166	0.00278	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-DQB1—narcolepsy	0.00166	0.00276	CbGpPWpGaD
Acetylsalicylic acid—TP53—Apoptosis—TNF—narcolepsy	0.00165	0.00274	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00163	0.00272	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00163	0.00272	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Overview of nanoparticle effects—TNF—narcolepsy	0.00159	0.00265	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—HCRT—narcolepsy	0.00157	0.00262	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—TNF alpha Signaling Pathway—TNF—narcolepsy	0.00155	0.00258	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—NPS—narcolepsy	0.00153	0.00255	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—TAC1—narcolepsy	0.00153	0.00255	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HCRTR2—narcolepsy	0.00143	0.00239	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HCRTR1—narcolepsy	0.00143	0.00239	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HCRT—narcolepsy	0.00143	0.00238	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HCRT—narcolepsy	0.00143	0.00238	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.00143	0.00238	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00141	0.00235	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—PENK—narcolepsy	0.0014	0.00233	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—P2RY11—narcolepsy	0.00138	0.00231	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—CPT1B—narcolepsy	0.00132	0.00221	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TWEAK Signaling Pathway—TNF—narcolepsy	0.00129	0.00215	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00128	0.00213	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—brain—narcolepsy	0.00127	0.00318	CbGeAlD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—PENK—narcolepsy	0.00127	0.00212	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—PENK—narcolepsy	0.00127	0.00212	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HLA-DRB1—narcolepsy	0.00126	0.0021	CbGpPWpGaD
Acetylsalicylic acid—TP53—Spinal Cord Injury—TNF—narcolepsy	0.00125	0.00209	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00121	0.00202	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF receptor signaling pathway —TNF—narcolepsy	0.0012	0.002	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—TRH—narcolepsy	0.00119	0.00198	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HCRT—narcolepsy	0.00118	0.00196	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HCRTR2—narcolepsy	0.00115	0.00191	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HCRTR1—narcolepsy	0.00115	0.00191	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HCRTR1—narcolepsy	0.00113	0.00189	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HCRTR2—narcolepsy	0.00113	0.00189	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.00111	0.00186	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—P2RY11—narcolepsy	0.00111	0.00185	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—P2RY11—narcolepsy	0.0011	0.00183	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—TRH—narcolepsy	0.00108	0.0018	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—TRH—narcolepsy	0.00108	0.0018	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HLA-DQA1—narcolepsy	0.00107	0.00179	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00107	0.00179	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PENK—narcolepsy	0.00105	0.00175	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—HRH3—narcolepsy	0.00104	0.00174	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cardiac Hypertrophic Response—TNF—narcolepsy	0.00104	0.00173	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HCRTR2—narcolepsy	0.00103	0.00171	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HCRTR2—narcolepsy	0.00103	0.00171	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HCRTR1—narcolepsy	0.00103	0.00171	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HCRTR1—narcolepsy	0.00103	0.00171	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-DQA1—narcolepsy	0.00102	0.0017	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00102	0.00169	CbGpPWpGaD
Acetylsalicylic acid—TP53—Apoptosis—TNF—narcolepsy	0.00101	0.00168	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HLA-DQB1—narcolepsy	0.00101	0.00168	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SOCS2—narcolepsy	0.00101	0.00168	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.001	0.00167	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—P2RY11—narcolepsy	0.00099	0.00165	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—P2RY11—narcolepsy	0.00099	0.00165	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000952	0.00159	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRH3—narcolepsy	0.000947	0.00158	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRH3—narcolepsy	0.000947	0.00158	CbGpPWpGaD
Acetylsalicylic acid—TP53—MAPK Signaling Pathway—TNF—narcolepsy	0.000945	0.00158	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HCRT—narcolepsy	0.000942	0.00157	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HCRT—narcolepsy	0.000931	0.00155	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR ligand binding—HTR2A—narcolepsy	0.00092	0.00153	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TRH—narcolepsy	0.000892	0.00149	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00087	0.00145	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—NPS—narcolepsy	0.000864	0.00144	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—TAC1—narcolepsy	0.000864	0.00144	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000863	0.00144	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—TNF—narcolepsy	0.000855	0.00143	CbGpPWpGaD
Acetylsalicylic acid—TP53—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000853	0.00142	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HCRT—narcolepsy	0.000842	0.0014	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HCRT—narcolepsy	0.000842	0.0014	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.00084	0.0014	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PENK—narcolepsy	0.00084	0.0014	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PENK—narcolepsy	0.00083	0.00138	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000827	0.00138	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000822	0.00137	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.000786	0.00131	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—NPS—narcolepsy	0.000785	0.00131	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—TAC1—narcolepsy	0.000785	0.00131	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—NPS—narcolepsy	0.000785	0.00131	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—TAC1—narcolepsy	0.000785	0.00131	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000783	0.00131	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRH3—narcolepsy	0.000782	0.0013	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HLA-DRB1—narcolepsy	0.000764	0.00128	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000762	0.00127	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PENK—narcolepsy	0.000751	0.00125	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PENK—narcolepsy	0.000751	0.00125	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TNF—narcolepsy	0.00074	0.00123	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.00074	0.00123	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000738	0.00123	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.000732	0.00122	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000724	0.00121	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TRH—narcolepsy	0.000714	0.00119	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TRH—narcolepsy	0.000706	0.00118	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000691	0.00115	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—TNF—narcolepsy	0.000688	0.00115	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000673	0.00112	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TAC1—narcolepsy	0.000648	0.00108	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NPS—narcolepsy	0.000648	0.00108	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TRH—narcolepsy	0.000638	0.00106	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TRH—narcolepsy	0.000638	0.00106	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.000634	0.00106	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRH3—narcolepsy	0.000626	0.00104	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRH3—narcolepsy	0.000619	0.00103	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-DQA1—narcolepsy	0.000617	0.00103	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000598	0.000997	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—TNF—narcolepsy	0.000587	0.000979	CbGpPWpGaD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—TNF—narcolepsy	0.000583	0.000973	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-DQB1—narcolepsy	0.000577	0.000963	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CHKB—narcolepsy	0.00057	0.000951	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000562	0.000937	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRH3—narcolepsy	0.00056	0.000933	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRH3—narcolepsy	0.00056	0.000933	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000559	0.000932	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-DQA1—narcolepsy	0.000552	0.000921	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—HTR2A—narcolepsy	0.00052	0.000867	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NPS—narcolepsy	0.000519	0.000865	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TAC1—narcolepsy	0.000519	0.000865	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-DQB1—narcolepsy	0.000516	0.000861	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NPS—narcolepsy	0.000513	0.000855	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TAC1—narcolepsy	0.000513	0.000855	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HCRTR2—narcolepsy	0.00051	0.000851	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HCRTR1—narcolepsy	0.00051	0.000851	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000502	0.000837	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000495	0.000825	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—P2RY11—narcolepsy	0.000493	0.000821	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TNF—narcolepsy	0.000474	0.000791	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HTR2A—narcolepsy	0.000472	0.000788	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HTR2A—narcolepsy	0.000472	0.000788	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—TNF—narcolepsy	0.000466	0.000777	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TAC1—narcolepsy	0.000464	0.000773	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TAC1—narcolepsy	0.000464	0.000773	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NPS—narcolepsy	0.000464	0.000773	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NPS—narcolepsy	0.000464	0.000773	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000457	0.000763	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CHKB—narcolepsy	0.000453	0.000755	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000452	0.000755	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HLA-DRB1—narcolepsy	0.000439	0.000732	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TNF—narcolepsy	0.000425	0.000709	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000423	0.000706	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HCRT—narcolepsy	0.000419	0.000698	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HLA-DRB1—narcolepsy	0.000393	0.000655	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HTR2A—narcolepsy	0.00039	0.00065	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CPT1B—narcolepsy	0.000387	0.000646	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—TNF—narcolepsy	0.000377	0.000629	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PENK—narcolepsy	0.000373	0.000623	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TNF—narcolepsy	0.000368	0.000614	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CHKB—narcolepsy	0.000368	0.000614	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CHKB—narcolepsy	0.000366	0.000611	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—TNF—narcolepsy	0.000361	0.000602	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Allograft Rejection—TNF—narcolepsy	0.00036	0.0006	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CHKB—narcolepsy	0.000329	0.000548	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000322	0.000537	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CHKB—narcolepsy	0.000321	0.000535	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TRH—narcolepsy	0.000317	0.000529	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HTR2A—narcolepsy	0.000312	0.00052	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HTR2A—narcolepsy	0.000308	0.000514	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CPT1B—narcolepsy	0.000308	0.000513	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CHKB—narcolepsy	0.0003	0.0005	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HTR2A—narcolepsy	0.000279	0.000465	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HTR2A—narcolepsy	0.000279	0.000465	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRH3—narcolepsy	0.000278	0.000464	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQA1—narcolepsy	0.000274	0.000458	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQB1—narcolepsy	0.000257	0.000428	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000251	0.000418	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CPT1B—narcolepsy	0.00025	0.000417	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CPT1B—narcolepsy	0.000249	0.000415	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TAC1—narcolepsy	0.000231	0.000385	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NPS—narcolepsy	0.000231	0.000385	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000223	0.000373	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CPT1B—narcolepsy	0.000218	0.000364	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000204	0.00034	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DRB1—narcolepsy	0.000195	0.000326	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000178	0.000296	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HTR2A—narcolepsy	0.000139	0.000231	CbGpPWpGaD
